Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunction

K. D. Kieburtz, D. W. Giang, R. B. Schiffer and N. Vakil
Department of Neurology, University of Rochester, School of Medicine, NY 14642.

An increased prevalence of vitamin B12 deficiency has been reported in patients infected by the human immunodeficiency virus (HIV). We report an unexpectedly high prevalence (20%) of such abnormal vitamin B12 metabolism in a population of HIV-infected patients referred for neurological evaluation. This abnormality was associated with both peripheral neuropathy and myelopathy. A majority of those treated with cyanocobalamin had a therapeutic response. Selected neuropathological results suggest a relationship between vitamin B12 deficiency and vacuolar myelopathy. Vitamin B12 deficiency may be a frequent and treatable cause of neurological dysfunction in patients with HIV infection.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of AIDS-associated myelopathy with L-methionine: A placebo-controlled study
Di Rocco et al.
Neurology 2004;63:1270-1275.
ABSTRACT | FULL TEXT  

Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy
Di Rocco et al.
Neurology 2002;58:730-735.
ABSTRACT | FULL TEXT  

Distal Sensory Polyneuropathy in a Cohort of HIV-Infected Children Over Five Years of Age
Araújo et al.
Pediatrics 2000;106:35e-35.
ABSTRACT | FULL TEXT  

Prevalence of peripheral neuropathy in injection drug users
Berger et al.
Neurology 1999;53:592-592.
ABSTRACT | FULL TEXT  

Peripheral Nerve Function in HIV Infection: Clinical, Electrophysiologic, and Laboratory Findings
Tagliati et al.
Arch Neurol 1999;56:84-89.
ABSTRACT | FULL TEXT  

Peripheral Neuropathy in HIV Disease
AIDS Clin Care 1998;1998:1-1.
FULL TEXT  

Low Serum Vitamin B-12 Concentrations Are Associated With Faster Human Immunodeficiency Virus Type 1 (HIV-1) Disease Progression
Tang et al.
J. Nutr. 1997;127:345-351.
ABSTRACT | FULL TEXT  

Human Immunodeficiency Virus Early Intervention Physician Guidelines, Second Edition
Advisory Group on HIV Early Intervention, Second E
Arch Fam Med 1994;3:988-1002.
ABSTRACT